FSD Pharma (CSE: HUGE) (OTC: FSDDF) Investor Presentation by Dr. Raza Bokhari New Green Frontier Cannabis Investor Conference

– Second Quarter Total Revenue Grows by 24% Year-Over-Year- Second Quarter Highlighted by 249% Increase in Product Revenue- Company to Host Q2 2019 Financial Results Conference Call on Thursday, August 15, 2019, at 4:15 p.m. […]

Company in position for pre-sales license inspection, last step to issuance of a Sales License FSD Pharma Inc. (“FSD Pharma” or the “Company”) (OTC: FSDDF) (cse:HUGE)(fra:0K9) is pleased to announce that its wholly-owned subsidiary, FV […]

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) FSD Pharma Inc. (“FSD Pharma”)(OTC: FSDDF)  and Solarvest BioEnergy Inc. (SVS) (“Solarvest”) ()Parties”), a technology company which has developed an algal-based flexible production platform […]